A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1992
03/25/1992	CN1059729A Polypeptide compound and process for preparation thereof
03/25/1992	CN1059659A Diagnosis and treatment of viral hepatitis
03/25/1992	CA2052022A1 Peptides having thrombospondin-like activity and their therapeutic use
03/25/1992	CA2051749A1 Cell adhesion molecule
03/25/1992	CA2050817A1 Hiv-neutralizing rat monoclonal antibodies against pb-1
03/24/1992	US5099004 Antibodies such as monoclonal antibodies
03/24/1992	US5099003 Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
03/24/1992	US5099002 Sequential improved method for treatment of human blood-clotting factor products
03/24/1992	US5099001 Process for the production of thyroglobulin
03/24/1992	US5098997 Vaccines for Haemophilus influenzae
03/24/1992	US5098996 Process for introducing fluorine into biologically active materials
03/24/1992	US5098995 GRF Analogs VIIA
03/24/1992	US5098910 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
03/24/1992	US5098893 Storage of materials
03/24/1992	US5098892 Angiotensin converting enzyme inhibitors as hypotensive agents
03/24/1992	US5098891 Binding between living mineralized tissue by regeneration
03/24/1992	US5098889 Cognition activators, angiotensin converting enzyme inhibitors
03/24/1992	US5098888 Cholinergic agents and antispasmodic agents
03/24/1992	US5098887 Angiotensin converting enzyme inhibitor
03/24/1992	US5098840 Epidermal growth factor with a longer blood half-life
03/24/1992	US5098833 DNA sequence encoding a functional domain of a lymphocyte homing receptor
03/24/1992	US5098722 Method of manufacturing iron-fortified beverage
03/24/1992	US5098705 Bioinsecticides
03/24/1992	US5098703 Interferon-alpha 76
03/24/1992	US5098702 Anticarcinogenic agents
03/24/1992	CA1298035C Antitumor amino acid and peptide derivatives of 1,4- bis¬(aminoalkyl andhydroxyaminoalkyl)amino\|-5, 8-dihydroxyanthraquinones
03/24/1992	CA1298034C Amino acid derivatives
03/24/1992	CA1298033C Dipeptide derivative of fatty acid
03/24/1992	CA1298032C Method of preparing alpha-1-proteinase inhibitor
03/24/1992	CA1297825C Antibiotics called "chloropolysporins b and c" a process for their preparation, and their therapeutic and veterinary use
03/24/1992	CA1297816C Platelet function inhibiting monoclonal antibody fragment
03/24/1992	CA1297815C Fibrinogen blocking monoclonal antibody
03/24/1992	CA1297792C Fibrinolytic composition
03/24/1992	CA1297791C Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
03/24/1992	CA1297790C Multiplication inhibitor for bacillus cereus
03/24/1992	CA1297789C Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
03/24/1992	CA1297788C Treatment of aids virus with recombinant human alpha interferon
03/22/1992	WO1992005266A2 Packaging cells
03/22/1992	WO1992004912A1 Composition for inducing granulocyte production or b cell production in peripheral blood
03/22/1992	CA2051975A1 Polypeptide
03/22/1992	CA2051974A1 Polypeptide
03/22/1992	CA2051796A1 Vascular endothelial cell growth factor ii
03/21/1992	CA2051721A1 Nasal pharmaceutical composition
03/20/1992	WO1992004918A1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates
03/20/1992	WO1992004911A1 Substantially pure interleukin-9 receptor and uses thereof
03/19/1992	WO1992005273A1 Gene therapy for cystic fibrosis
03/19/1992	WO1992004632A1 Methods for the diagnosis and treatment of diabetes
03/19/1992	WO1992004464A1 Monoclonal antibodies against tenascin
03/19/1992	WO1992004460A1 Genetically engineered coccidiosis vaccine
03/19/1992	WO1992004450A1 Hybrid plasminogen activators
03/19/1992	WO1992004446A1 Cloning of chicken anaemia dna
03/19/1992	WO1992004445A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
03/19/1992	WO1992004442A1 Glial antiproliferative proteins
03/19/1992	WO1992004380A1 Specific binding agents
03/19/1992	WO1992004379A1 A new growth factor isolated from porcine spleen
03/19/1992	WO1992004378A1 Recombinant agents affecting thrombosis
03/19/1992	WO1992004376A1 Novel chemotactic factor
03/19/1992	WO1992004374A1 Novel polypeptide and anti-hiv drug prepared therefrom
03/19/1992	WO1992004373A1 Peptide having antiallergic activity
03/19/1992	WO1992004370A1 Modified di- and tripeptidyl immunosuppressive compounds
03/19/1992	WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
03/19/1992	WO1992004320A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED Trp DERIVATIVES
03/19/1992	WO1992004055A1 Immunosuppressant composition
03/19/1992	WO1992004051A1 Monoclonal antibody active against the interleukin-2 receptor
03/19/1992	WO1992004045A1 Novel cholecystokinin antagonists, their preparation and therapeutic use
03/19/1992	WO1992004044A1 Use of il-4 to treat solid tumors
03/19/1992	WO1992004043A1 Pharmaceutical compositions for use in treating parkinson's disease
03/19/1992	WO1992004042A1 Glucagon analogs with asp9 replacements or deletions
03/19/1992	WO1992004041A1 Remedy for corneal damages
03/19/1992	WO1992004039A1 Regulation of cell proliferation and differentiation using peptides
03/19/1992	WO1992004038A1 Pro-drugs for cck antagonists
03/19/1992	WO1992004037A1 Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
03/19/1992	WO1992004035A1 Anti-inflammatory factor, method of isolation, and use
03/19/1992	WO1992004033A1 Methods for inhibiting rejection of transplanted tissue
03/19/1992	WO1992004009A1 Liposomes
03/19/1992	WO1992003918A1 Transgenic non-human animals capable of producing heterologous antibodies
03/19/1992	WO1992002612A3 Tissue plasminogen activator variants with decreased clearance
03/19/1992	WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide
03/19/1992	DE4120296A1 Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.
03/19/1992	DE4029227A1 Arzneimittel enthaltend cd14 Medicines containing CD14
03/19/1992	DE4028955A1 Monoklonale antikoerper gegen den interleukin 2-rezeptor Monoclonal antibodies against the interleukin 2 receptor
03/19/1992	CA2091170A1 Use of il-4 to treat solid tumors
03/19/1992	CA2090410A1 Antithrombosis agents
03/19/1992	CA2088195A1 Cholecystokinin antagonists, their preparation and therapeutic use
03/19/1992	CA2025569A1 Oxidizing-energizing composition
03/18/1992	WO1992005272A1 Method and composition for controlling proliferation of cells
03/18/1992	WO1992005191A1 Fungicidally active compounds
03/18/1992	EP0475851A1 Antioxydant system based on basic aminoacid and a tocopherol
03/18/1992	EP0475746A1 Human and murine interleukin-5 receptor
03/18/1992	EP0475719A2 Platelet derived growth regulating peptide
03/18/1992	EP0475657A2 Pentapeptide and salts thereof having specific inhibiting effect of epidermal cell proliferation
03/18/1992	EP0475623A1 Genetic mechanisms of tumor supression
03/18/1992	EP0475394A2 Rat C-type natriuretic peptide cDNA and precursor protein
03/18/1992	EP0475374A2 Use of branched chain amino acids to effect diaphragm contractility and fatigue
03/18/1992	EP0475292A2 Human luteinizing hormone-human chorionic gonadotropin receptor (Human LH/hCG receptor)
03/18/1992	EP0475291A1 A novel biologically active peptide derived from chicken (chicken CNP)
03/18/1992	EP0475290A1 A novel biologically active peptide derived from frog (frog CNP)
03/18/1992	EP0475230A1 Methods of conjugating actinomycin D
03/18/1992	EP0475185A1 DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
03/18/1992	EP0474979A1 Heparin binding neurotrophic factor gene sequence

1 ... 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 ... 3163